FEES to Determine Neurological Intensive Care Patients' Oral Diet

Sponsor
University of Giessen (Other)
Overall Status
Completed
CT.gov ID
NCT03753841
Collaborator
(none)
125
1
2
32.1
3.9

Study Details

Study Description

Brief Summary

Dysphagia is associated with high rates of mortality and morbidity. Adjusting the oral diet of ICU-patients based on flexible endoscopic evaluation of swallowing (FEES) findings might reduce pneumonia rate, mortality and need for intubation/tracheotomy.

Condition or Disease Intervention/Treatment Phase
  • Other: Adjustment of oral diet
N/A

Detailed Description

Dysphagia, a common complication in neurological disorders, leads to high rates of mortality and morbidity. It is prevalent in critically ill patients, especially those who need mechanical ventilation. The investigators therefore investigate the effect of adjusting the oral diet of our intensive care unit (ICU) patients based on flexible endoscopic evaluation of swallowing (FEES) findings, thereby assessing the impact of FEES on a neurological ICU. All patients treated on the investigators neurological ICU will be eligible for this study.

The investigators will correlate findings with baseline data, disability status, pneumonia and duration of hospitalisation, as well as a need for mechanical ventilation or a tracheotomy.

Study Design

Study Type:
Interventional
Actual Enrollment :
125 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Flexible Endoscopic Evaluation of Swallowing (FEES) to Determine Neurological Patients' Oral Diet
Actual Study Start Date :
Jan 14, 2014
Actual Primary Completion Date :
Sep 3, 2016
Actual Study Completion Date :
Sep 16, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Adjustment of oral diet

Patients who need a change in their diet regime, in whom FEES shows that they have not the adequat diet.

Other: Adjustment of oral diet
Adjustment of oral diet based on findings in fiberendoscopic evaluation of swallowing (FEES)

No Intervention: No adjustment of oral diet

Patients who have the adequat diet based on FEES findings.

Outcome Measures

Primary Outcome Measures

  1. Pneumonia Rate [Up to 130 days]

    self-explanatory

  2. Mortality [Up to 130 days]

    self-explanatory

Secondary Outcome Measures

  1. Length of stay in hospital [Up to 130 days]

    self-explanatory

  2. Intubation/Tracheotomy [Up to 130 days]

    Rate of Intubation/Tracheotomy

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Treatment on neurological ICU

  • Clinical suspicion of Dysphagia

Exclusion Criteria:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universitätsklinikum Gießen Gießen Hessen Germany 35392

Sponsors and Collaborators

  • University of Giessen

Investigators

  • Principal Investigator: Tobias Braun, M.D., University of Giessen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tobias Braun, Principal Investigator, University of Giessen
ClinicalTrials.gov Identifier:
NCT03753841
Other Study ID Numbers:
  • GI 208/16-1
First Posted:
Nov 27, 2018
Last Update Posted:
Nov 27, 2018
Last Verified:
Nov 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tobias Braun, Principal Investigator, University of Giessen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 27, 2018